BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharma S, Carballo M, Feld JJ, Janssen HL. Immigration and viral hepatitis. J Hepatol. 2015;63:515-522. [PMID: 25962882 DOI: 10.1016/j.jhep.2015.04.026] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Thijssen M, Lemey P, Amini-Bavil-Olyaee S, Dellicour S, Alavian SM, Tacke F, Verslype C, Nevens F, Pourkarim MR. Mass migration to Europe: an opportunity for elimination of hepatitis B virus? Lancet Gastroenterol Hepatol 2019;4:315-23. [PMID: 30860067 DOI: 10.1016/S2468-1253(19)30014-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 11.0] [Reference Citation Analysis]
2 Sanna A, Le Strat Y, Roudot-Thoraval F, Deuffic Burban S, Carrieri P, Delarocque-Astagneau E, Larsen C. Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014. Euro Surveill 2017;22:30582. [PMID: 28797326 DOI: 10.2807/1560-7917.ES.2017.22.30.30582] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Liu Z, Xu K, Jiang Y, Cai N, Fan J, Mao X, Suo C, Jin L, Zhang T, Chen X. Global trend of aetiology-based primary liver cancer incidence from 1990 to 2030: a modelling study. Int J Epidemiol. 2021;50:128-142. [PMID: 33349860 DOI: 10.1093/ije/dyaa196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Busschots D, Toghanian S, Bielen R, Salomonsson S, Koc ÖM, Hendrickx G, Jadoul M, Nevens F, Sokal E, Brixko C, Peerlinck K, Apers L, Robaeys G, Lazarus JV. Eliminating viral hepatitis C in Belgium: the micro-elimination approach. BMC Infect Dis 2020;20:181. [PMID: 32106819 DOI: 10.1186/s12879-020-4898-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
5 Ha E, Kim F, Blanchard J, Juon HS. Prevalence of Chronic Hepatitis B and C Infection in Mongolian Immigrants in the Washington, District of Columbia, Metropolitan Area, 2016-2017. Prev Chronic Dis 2019;16:E08. [PMID: 30676936 DOI: 10.5888/pcd16.180104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 He Q, He Q, Qin X, Li S, Li T, Xie L, Deng Y, He Y, Chen Y, Wei Z. The Relationship between Inflammatory Marker Levels and Hepatitis C Virus Severity. Gastroenterol Res Pract 2016;2016:2978479. [PMID: 28090206 DOI: 10.1155/2016/2978479] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
7 McKee G, Butt ZA, Wong S, Salway T, Gilbert M, Wong J, Alvarez M, Chapinal N, Darvishian M, Tyndall MW, Krajden M, Janjua NZ. Syndemic Characterization of HCV, HBV, and HIV Co-infections in a Large Population Based Cohort Study. EClinicalMedicine 2018;4-5:99-108. [PMID: 31193601 DOI: 10.1016/j.eclinm.2018.10.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
8 Boga JA, Casado L, Fernández-Suarez J, Moran N, Rodríguez-Perez M, Martínez-Sela M, Pérez A, Garcia-Perez A, Menendez C, Santos S, Rodriguez-Guardado A. Screening Program for Imported Diseases in Immigrant Women: Analysis and Implications from a Gender-Oriented Perspective. Am J Trop Med Hyg 2020;103:480-4. [PMID: 32342844 DOI: 10.4269/ajtmh.19-0687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Coppola N, Alessio L, Onorato L, Sagnelli C, Macera M, Sagnelli E, Pisaturo M. Epidemiology and management of hepatitis C virus infections in immigrant populations. Infect Dis Poverty 2019;8:17. [PMID: 30871599 DOI: 10.1186/s40249-019-0528-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 10.5] [Reference Citation Analysis]
10 Mipatrini D, Stefanelli P, Severoni S, Rezza G. Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence. Pathog Glob Health 2017;111:59-68. [PMID: 28165878 DOI: 10.1080/20477724.2017.1281374] [Cited by in Crossref: 78] [Cited by in F6Publishing: 56] [Article Influence: 19.5] [Reference Citation Analysis]
11 Ortiz E, Scanlon B, Mullens A, Durham J. Effectiveness of Interventions for Hepatitis B and C: A Systematic Review of Vaccination, Screening, Health Promotion and Linkage to Care Within Higher Income Countries. J Community Health 2020;45:201-18. [PMID: 31332639 DOI: 10.1007/s10900-019-00699-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
12 Rigopoulou EI, Gatselis NK, Galanis K, Lygoura V, Gabeta S, Zachou K, Dalekos GN. The changing epidemiology of hepatitis B in Greece. Ann Gastroenterol 2021;34:431-7. [PMID: 33948070 DOI: 10.20524/aog.2021.0614] [Reference Citation Analysis]
13 Krajden M, Cook D, Janjua NZ. Contextualizing Canada’s hepatitis C virus epidemic. CanLivJ 2018;1:218-30. [DOI: 10.3138/canlivj.2018-0011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
14 Du Y, Han X, Ding YB, Yin JH, Cao GW. Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects. World J Gastroenterol 2016;22:6565-72. [PMID: 27547000 DOI: 10.3748/wjg.v22.i29.6565] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Pacelli B, Zengarini N, Broccoli S, Caranci N, Spadea T, Di Girolamo C, Cacciani L, Petrelli A, Ballotari P, Cestari L, Grisotto L, Giorgi Rossi P; IN-LiMeS Group. Differences in mortality by immigrant status in Italy. Results of the Italian Network of Longitudinal Metropolitan Studies. Eur J Epidemiol 2016;31:691-701. [PMID: 27461270 DOI: 10.1007/s10654-016-0177-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
16 Jackson Y, Santos L, Arm-Vernez I, Mauris A, Wolff H, Chappuis F, Getaz L. Prevalence of chronic infections and susceptibility to measles and varicella-zoster virus in Latin American immigrants. Infect Dis Poverty 2016;5:41. [PMID: 27164954 DOI: 10.1186/s40249-016-0136-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
17 Roingeard P, Beaumont E. Hepatitis C Vaccine: 10 Good Reasons for Continuing. Hepatology. 2020;71:1845-1850. [PMID: 32060946 DOI: 10.1002/hep.31182] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
18 Aibekova L, Foley B, Hortelano G, Raees M, Abdraimov S, Toichuev R, Ali S. Molecular epidemiology of HIV-1 subtype A in former Soviet Union countries. PLoS One 2018;13:e0191891. [PMID: 29389951 DOI: 10.1371/journal.pone.0191891] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
19 Smolders EJ, Burger DM, Feld JJ, Kiser JJ. Review article: clinical pharmacology of current and investigational hepatitis B virus therapies. Aliment Pharmacol Ther. 2020;51:231-243. [PMID: 31840863 DOI: 10.1111/apt.15581] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
20 Lau KCK, Shaheen AA, Aspinall AA, Ricento Ba T, Qureshi Mba K, Congly SE, Borman MA, Jayakumar S, Eksteen B, Lee SS, Stinton L, Swain MG, Burak KW, Coffin CS. Hepatitis B virus testing and linkage to care in a Canadian urban tertiary referral centre: a retrospective cohort study. CMAJ Open 2017;5:E431-6. [PMID: 28596186 DOI: 10.9778/cmajo.20170002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
21 Zheng J, Lin X, Wang X, Zheng L, Lan S, Jin S, Ou Z, Wu J. In Silico Analysis of Epitope-Based Vaccine Candidates against Hepatitis B Virus Polymerase Protein. Viruses 2017;9:E112. [PMID: 28509875 DOI: 10.3390/v9050112] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 9.5] [Reference Citation Analysis]
22 Kirdar S, Aydin N, Tiryaki Y, Ertugrul B, Coskun A, Bilgen M. Dynamics of HCV epidemiology in Aydin province of Turkey and the associated factors. APMIS 2018;126:109-13. [PMID: 29271117 DOI: 10.1111/apm.12790] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Greenaway C, Castelli F. Infectious diseases at different stages of migration: an expert review. J Travel Med 2019;26:taz007. [PMID: 30726941 DOI: 10.1093/jtm/taz007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 29.0] [Reference Citation Analysis]
24 Yasseen AS 3rd, Kwong JC, Feld JJ, Janjua NZ, Greenaway C, Lapointe-Shaw L, Sherman M, Mazzulli T, Kustra R, MacDonald L, Sander B, Crowcroft NS. Viral hepatitis C cascade of care: A population-level comparison of immigrant and long-term residents. Liver Int 2021;41:1775-88. [PMID: 33655665 DOI: 10.1111/liv.14840] [Reference Citation Analysis]
25 Miquel M, Pardo A, Forné M, Martínez-Alpin G, Rodríguez-Castellano A, Casas M, Rosinach M, Roget M, Dalmau B, Temiño R, Quer JC, Sanchez-Delgado J, Ortiz J, Vergara M. Current trends in access to treatment for hepatitis B in immigrants vs non-immigrants. Gastroenterol Rep (Oxf) 2020;8:362-6. [PMID: 33163191 DOI: 10.1093/gastro/goaa010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Sagnelli E, Alessio L, Sagnelli C, Gualdieri L, Pisaturo M, Minichini C, Di Caprio G, Starace M, Onorato L, Macera M, Scotto G, Coppola N. Hepatitis B Virus Genotypes, Epidemiological Characteristics, and Clinical Presentation of HBV Chronic Infection in Immigrant Populations Living in Southern Italy. Hepat Mon 2017;17. [DOI: 10.5812/hepatmon.13260] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
27 Behzadifar M, Azari S, Gorji HA, Martini M, Bragazzi NL. The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges. J Prev Med Hyg 2020;61:E109-18. [PMID: 32490276 DOI: 10.15167/2421-4248/jpmh2020.61.1.1438] [Reference Citation Analysis]
28 Yang Y, Jin L, Tian Z, Guo D, Yao N, Li Q, Jiang Z, Yang D, Tang X, Li H, He Y, Liu J, Chen T, Zhao Y. The association of adverse outcomes in the mother with disease progression in offspring in families with clusters of hepatitis B virus infection and unfavorable prognoses in Northwest China. Medicine (Baltimore) 2018;97:e12266. [PMID: 30235671 DOI: 10.1097/MD.0000000000012266] [Reference Citation Analysis]
29 Meng X, Wei G, Chang Q, Peng R, Shi G, Zheng P, He F, Wang W, Ming L. The platelet-to-lymphocyte ratio, superior to the neutrophil-to-lymphocyte ratio, correlates with hepatitis C virus infection. Int J Infect Dis. 2016;45:72-77. [PMID: 26948479 DOI: 10.1016/j.ijid.2016.02.025] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
30 Suijkerbuijk AWM, van Hoek AJ, Koopsen J, de Man RA, Mangen MJ, de Melker HE, Polder JJ, de Wit GA, Veldhuijzen IK. Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country. PLoS One 2018;13:e0207037. [PMID: 30408079 DOI: 10.1371/journal.pone.0207037] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
31 Ott JJ, Horn J, Krause G, Mikolajczyk RT. Time trends of chronic HBV infection over prior decades - A global analysis. J Hepatol. 2017;66:48-54. [PMID: 27592304 DOI: 10.1016/j.jhep.2016.08.013] [Cited by in Crossref: 83] [Cited by in F6Publishing: 71] [Article Influence: 16.6] [Reference Citation Analysis]
32 Yao WL, Ikeda S, Tsukamoto Y, Shindo K, Otakaki Y, Qin M, Iwasawa Y, Takeuchi F, Kaname Y, Chou YC, Chang C, Watashi K, Wakita T, Noda T, Kato H, Fujita T. Establishment of a human hepatocellular cell line capable of maintaining long-term replication of hepatitis B virus. Int Immunol 2017;29:109-20. [PMID: 28338936 DOI: 10.1093/intimm/dxx012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
33 Shield KD, Marant Micallef C, de Martel C, Heard I, Megraud F, Plummer M, Vignat J, Bray F, Soerjomataram I. New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis. Eur J Epidemiol 2018;33:263-74. [DOI: 10.1007/s10654-017-0334-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
34 Daw MA, El-Bouzedi A, Ahmed MO, Dau AA, Agnan MM; In association with the Libyan Study Group of Hepatitis & amp; HIV. Epidemiology of hepatitis C virus and genotype distribution in immigrants crossing to Europe from North and sub-Saharan Africa. Travel Med Infect Dis. 2016;14:517-526. [PMID: 27502972 DOI: 10.1016/j.tmaid.2016.05.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
35 Rosa-Hezode I, Chousterman M, Costes L, Labourdette C, Elghozi B, Krastinova E, Roudot-Thoraval F. Cascade of care for migrants tested Hepatitis C antibodies positive in France through a systematic screening programme: The PRECAVIR study. J Viral Hepat 2019;26:1496-9. [PMID: 31433886 DOI: 10.1111/jvh.13192] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Marot A, Belaid A, Orlent H, Sersté T, Michielsen P, Colle I, Laleman W, de Galocsy C, Reynaert H, D'Heygere F, Moreno C, Doerig C, Henrion J, Deltenre P. Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients. Clin Res Hepatol Gastroenterol 2017;41:656-63. [PMID: 28867077 DOI: 10.1016/j.clinre.2017.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
37 Kamal SM. Hepatitis C Treatment in the Era of Direct-Acting Antiviral Agents. Hepatitis C in Developing Countries. Elsevier; 2018. pp. 209-46. [DOI: 10.1016/b978-0-12-803233-6.00017-5] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
38 Leask JD, Dillon JF. Review article: treatment as prevention - targeting people who inject drugs as a pathway towards hepatitis C eradication. Aliment Pharmacol Ther. 2016;44:145-156. [PMID: 27199103 DOI: 10.1111/apt.13673] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
39 Koc ÖM, Robaeys G, Yildirim B, Posthouwer D, Hens N, Koek GH. The influence of ethnicity on disease outcome in patients with chronic hepatitis B infection. J Med Virol 2019;91:623-9. [PMID: 30381836 DOI: 10.1002/jmv.25353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
40 Yuen MF, Chen DS, Dusheiko GM, Janssen HLA, Lau DTY, Locarnini SA, Peters MG, Lai CL. Hepatitis B virus infection. Nat Rev Dis Primers. 2018;4:18035. [PMID: 29877316 DOI: 10.1038/nrdp.2018.35] [Cited by in Crossref: 172] [Cited by in F6Publishing: 139] [Article Influence: 57.3] [Reference Citation Analysis]
41 Shaheen AA, AlMattooq M, Yazdanfar S, Burak KW, Swain MG, Congly SE, Borman MA, Lee SS, Myers RP, Coffin CS. Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriers. Aliment Pharmacol Ther. 2017;46:599-604. [PMID: 28707319 DOI: 10.1111/apt.14218] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
42 European Union HCV Collaborators. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study. Lancet Gastroenterol Hepatol 2017;2:325-36. [PMID: 28397696 DOI: 10.1016/S2468-1253(17)30045-6] [Cited by in Crossref: 145] [Cited by in F6Publishing: 55] [Article Influence: 36.3] [Reference Citation Analysis]
43 Ahmad AA, Falla AM, Duffell E, Noori T, Bechini A, Reintjes R, Veldhuijzen IK. Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries. BMC Infect Dis 2018;18:34. [PMID: 29325525 DOI: 10.1186/s12879-017-2921-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
44 Li C, He WQ. The impact of universal hepatitis B vaccine on the trend of liver cancer from the Global Burden of Disease Study 2017. Liver Int 2021;41:1762-74. [PMID: 33590659 DOI: 10.1111/liv.14821] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Cuypers L, Thijssen M, Shakibzadeh A, Sabahi F, Ravanshad M, Pourkarim MR. Next-generation sequencing for the clinical management of hepatitis C virus infections: does one test fits all purposes? Crit Rev Clin Lab Sci 2019;56:420-34. [PMID: 31317801 DOI: 10.1080/10408363.2019.1637394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
46 Hayashi M, Deng L, Chen M, Gan X, Shinozaki K, Shoji I, Hotta H. Interaction of the hepatitis B virus X protein with the lysine methyltransferase SET and MYND domain-containing 3 induces activator protein 1 activation. Microbiol Immunol 2016;60:17-25. [PMID: 26616333 DOI: 10.1111/1348-0421.12345] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
47 Ayele A, Abera D, Hailu M, Birhanu M, Desta K. Prevalence and associated risk factors for Hepatitis B and C viruses among refugees in Gambella, Ethiopia. BMC Public Health 2020;20:721. [PMID: 32429964 DOI: 10.1186/s12889-020-08893-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Elshafie BE, Osman KH, Macleod C, Hassan A, Bush S, Dejene M, Willis R, Chu B, Courtright P, Solomon AW. The Epidemiology of Trachoma in Darfur States and Khartoum State, Sudan: Results of 32 Population-Based Prevalence Surveys. Ophthalmic Epidemiol 2016;23:381-91. [PMID: 27841721 DOI: 10.1080/09286586.2016.1243718] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 6.3] [Reference Citation Analysis]
49 Kamstra R, Azoulay L, Steele R, Klein MB, Greenaway C. Hospitalizations in Immigrants and Nonimmigrants Diagnosed With Chronic Hepatitis C Infection in Québec. Clin Infect Dis 2016;63:1439-48. [PMID: 27501843 DOI: 10.1093/cid/ciw540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
50 Moore MS, Greene SK, Bocour A, Brown CM, Coyle JR, Kuncio D, Onofrey S, Patel MT, Winters A. Comprehensive nationwide chronic hepatitis C surveillance is necessary for accurate state-level prevalence estimates. J Viral Hepat 2019;26:1124-6. [PMID: 31087511 DOI: 10.1111/jvh.13124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Hu JH, Chen MY, Yeh CT, Lin HS, Lin MS, Huang TJ, Chang ML. Sexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients: A Community-Based Study in a Hepatitis B/Hepatitis C Virus Hyperendemic Area. Medicine (Baltimore) 2016;95:e3546. [PMID: 27149466 DOI: 10.1097/MD.0000000000003546] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
52 Heywood AE, Castelli F, Greenaway C. Migration Health: Highlights from Inaugural International Society of Travel Medicine (ISTM) Conference on Migration Health. Curr Infect Dis Rep 2019;21:48. [PMID: 31734735 DOI: 10.1007/s11908-019-0705-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Carr J, Cha DE, Shaltiel T, Zheng S, Siderides C, Golas B, Labow D, Magge D, Cohen N, Branch A, Sarpel U. African Immigrants in New York City with Hepatitis B-Related Hepatocellular Carcinoma Demonstrate High Morbidity and Mortality. J Immigr Minor Health 2021. [PMID: 33907933 DOI: 10.1007/s10903-021-01205-8] [Reference Citation Analysis]